{"id":9254,"date":"2020-10-23T17:41:23","date_gmt":"2020-10-23T21:41:23","guid":{"rendered":"https:\/\/imedcprod.wpengine.com\/medicaments-novateurs-canada-reagit-a-la-publication-des-lignes-directrices-definitives-du-conseil-dexamen-du-prix-des-medicaments-brevetes\/"},"modified":"2020-10-23T17:41:23","modified_gmt":"2020-10-23T21:41:23","slug":"medicaments-novateurs-canada-reagit-a-la-publication-des-lignes-directrices-definitives-du-conseil-dexamen-du-prix-des-medicaments-brevetes","status":"publish","type":"post","link":"https:\/\/innovativemedicines.ca\/fr\/actualites\/blogues\/medicaments-novateurs-canada-reagit-a-la-publication-des-lignes-directrices-definitives-du-conseil-dexamen-du-prix-des-medicaments-brevetes\/","title":{"rendered":"M\u00e9dicaments novateurs Canada r\u00e9agit \u00e0 la publication des Lignes directrices d\u00e9finitives du Conseil d\u2019examen du prix des m\u00e9dicaments brevet\u00e9s"},"content":{"rendered":"

D\u00c9CLARATION<\/p>\n

Ottawa, le 23 octobre 2020<\/strong>\u00a0\u2013 M\u00e9dicaments novateurs Canada (MNC) a fait la d\u00e9claration suivante en r\u00e9action \u00e0 la publication des Lignes directrices d\u00e9finitives du Conseil d\u2019examen du prix des m\u00e9dicaments brevet\u00e9s (CEPMB) aujourd\u2019hui\u00a0:<\/p>\n

\u00ab\u00a0Au cours des cinq derni\u00e8res ann\u00e9es, nous avons fait part de nos pr\u00e9occupations quant aux r\u00e9percussions n\u00e9gatives que les modifications apport\u00e9es par le CEPMB au R\u00e8glement sur les m\u00e9dicaments brevet\u00e9s<\/em> et \u00e0 ses Lignes directrices auront sur les patients canadiens. Les Lignes directrices d\u00e9finitives publi\u00e9es aujourd\u2019hui ne font rien pour dissiper ces inqui\u00e9tudes.<\/p>\n

\u00ab\u00a0Si elles sont mises en \u0153uvre, elles auront des r\u00e9percussions n\u00e9gatives sur les patients canadiens. Plus pr\u00e9cis\u00e9ment, de nouveaux m\u00e9dicaments novateurs ne seront pas lanc\u00e9s au Canada, privant ainsi les patients de nouveaux traitements susceptibles de changer leur vie; le nombre d\u2019essais cliniques au pays sera davantage r\u00e9duit; et le secteur des sciences de la vie perdra des investissements cruciaux.<\/p>\n

\u00ab\u00a0Le paroxysme d\u2019une crise de sant\u00e9 publique mondiale est le pire moment possible pour mettre en \u0153uvre des changements r\u00e9glementaires qui auront des r\u00e9percussions aussi directes et n\u00e9gatives sur les patients canadiens. La situation est d\u2019autant plus grave que les Lignes directrices publi\u00e9es aujourd\u2019hui sont le r\u00e9sultat d\u2019un processus de consultation inad\u00e9quat qui a largement ignor\u00e9 les pr\u00e9occupations importantes soulev\u00e9es, entre autres, par l\u2019industrie, les patients et les chercheurs.<\/p>\n

\u00ab\u00a0Heureusement, il est encore temps de trouver une meilleure solution. Nos membres sont toujours pr\u00eats \u00e0 travailler avec le gouvernement pour trouver une solution qui r\u00e9pond \u00e0 leurs importants objectifs d\u2019int\u00e9r\u00eat public, sans compromettre l\u2019acc\u00e8s des Canadiens aux nouveaux m\u00e9dicaments, ni faire fuir les investissements.<\/p>\n

\u00ab\u00a0Entre-temps, nous continuerons \u00e0 demander \u00e0 Sant\u00e9\u00a0Canada de retarder la mise en \u0153uvre des Lignes directrices d\u00e9finitives du CEPMB du 1er<\/sup>\u00a0janvier\u00a02021 jusqu\u2019\u00e0 ce que la crise de la COVID-19 soit pass\u00e9e. \u00c0 l\u2019heure actuelle, notre attention collective ne devrait porter que sur la d\u00e9couverte, le d\u00e9veloppement et l\u2019offre de m\u00e9dicaments pour traiter les personnes infect\u00e9es par le virus, et de vaccins pour enrayer la propagation de la COVID-19.\u00a0\u00bb<\/p>\n

\u00c0 propos de M\u00e9dicaments novateurs Canada<\/h2>\n

M\u00e9dicaments novateurs Canada est la voix nationale de l\u2019industrie pharmaceutique innovatrice canadienne. Nous plaidons en faveur de politiques qui permettent la d\u00e9couverte, le d\u00e9veloppement et la commercialisation de m\u00e9dicaments et vaccins novateurs qui am\u00e9liorent la vie de tous les Canadiens. Nous appuyons l\u2019engagement de nos membres d\u2019\u00eatre un partenaire pr\u00e9cieux du syst\u00e8me de sant\u00e9 canadien.<\/p>\n

\u2013\u00a030\u00a0\u2013<\/p>\n

Pour de plus amples renseignements\u00a0:<\/h2>\n

Samantha\u00a0Thompson
\nRelations avec les m\u00e9dias
\nT\u00e9l\u00e9phone\u00a0: 613\u00a0790-4555
\nCourriel\u00a0: sthompson@imc-mnc.ca<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

D\u00c9CLARATION Ottawa, le 23 octobre 2020\u00a0\u2013 M\u00e9dicaments novateurs Canada (MNC) a fait la d\u00e9claration suivante en r\u00e9action \u00e0 la publication […]<\/p>\n","protected":false},"author":4,"featured_media":13659,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"categories":[174],"tags":[],"topic":[],"team-member-id":[],"class_list":["post-9254","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-article-fr"],"yoast_head":"\nM\u00e9dicaments novateurs Canada r\u00e9agit \u00e0 la publication des Lignes directrices d\u00e9finitives du Conseil d\u2019examen du prix des m\u00e9dicaments brevet\u00e9s - Innovative Medicines Canada<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/innovativemedicines.ca\/fr\/actualites\/blogues\/medicaments-novateurs-canada-reagit-a-la-publication-des-lignes-directrices-definitives-du-conseil-dexamen-du-prix-des-medicaments-brevetes\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"M\u00e9dicaments novateurs Canada r\u00e9agit \u00e0 la publication des Lignes directrices d\u00e9finitives du Conseil d\u2019examen du prix des m\u00e9dicaments brevet\u00e9s - Innovative Medicines Canada\" \/>\n<meta property=\"og:description\" content=\"D\u00c9CLARATION Ottawa, le 23 octobre 2020\u00a0\u2013 M\u00e9dicaments novateurs Canada (MNC) a fait la d\u00e9claration suivante en r\u00e9action \u00e0 la publication […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/innovativemedicines.ca\/fr\/actualites\/blogues\/medicaments-novateurs-canada-reagit-a-la-publication-des-lignes-directrices-definitives-du-conseil-dexamen-du-prix-des-medicaments-brevetes\/\" \/>\n<meta property=\"og:site_name\" content=\"Innovative Medicines Canada\" \/>\n<meta property=\"article:published_time\" content=\"2020-10-23T21:41:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2022\/06\/terms-conditions-hero.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1281\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Alex Chambers\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Alex Chambers\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/innovativemedicines.ca\/fr\/actualites\/blogues\/medicaments-novateurs-canada-reagit-a-la-publication-des-lignes-directrices-definitives-du-conseil-dexamen-du-prix-des-medicaments-brevetes\/\",\"url\":\"https:\/\/innovativemedicines.ca\/fr\/actualites\/blogues\/medicaments-novateurs-canada-reagit-a-la-publication-des-lignes-directrices-definitives-du-conseil-dexamen-du-prix-des-medicaments-brevetes\/\",\"name\":\"M\u00e9dicaments novateurs Canada r\u00e9agit \u00e0 la publication des Lignes directrices d\u00e9finitives du Conseil d\u2019examen du prix des m\u00e9dicaments brevet\u00e9s - Innovative Medicines Canada\",\"isPartOf\":{\"@id\":\"https:\/\/innovativemedicines.ca\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/innovativemedicines.ca\/fr\/actualites\/blogues\/medicaments-novateurs-canada-reagit-a-la-publication-des-lignes-directrices-definitives-du-conseil-dexamen-du-prix-des-medicaments-brevetes\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/innovativemedicines.ca\/fr\/actualites\/blogues\/medicaments-novateurs-canada-reagit-a-la-publication-des-lignes-directrices-definitives-du-conseil-dexamen-du-prix-des-medicaments-brevetes\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2022\/06\/terms-conditions-hero.jpg\",\"datePublished\":\"2020-10-23T21:41:23+00:00\",\"author\":{\"@id\":\"https:\/\/innovativemedicines.ca\/fr\/#\/schema\/person\/9c9782d644563c5e4084ca674198eaa9\"},\"breadcrumb\":{\"@id\":\"https:\/\/innovativemedicines.ca\/fr\/actualites\/blogues\/medicaments-novateurs-canada-reagit-a-la-publication-des-lignes-directrices-definitives-du-conseil-dexamen-du-prix-des-medicaments-brevetes\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/innovativemedicines.ca\/fr\/actualites\/blogues\/medicaments-novateurs-canada-reagit-a-la-publication-des-lignes-directrices-definitives-du-conseil-dexamen-du-prix-des-medicaments-brevetes\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/innovativemedicines.ca\/fr\/actualites\/blogues\/medicaments-novateurs-canada-reagit-a-la-publication-des-lignes-directrices-definitives-du-conseil-dexamen-du-prix-des-medicaments-brevetes\/#primaryimage\",\"url\":\"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2022\/06\/terms-conditions-hero.jpg\",\"contentUrl\":\"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2022\/06\/terms-conditions-hero.jpg\",\"width\":1920,\"height\":1281},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/innovativemedicines.ca\/fr\/actualites\/blogues\/medicaments-novateurs-canada-reagit-a-la-publication-des-lignes-directrices-definitives-du-conseil-dexamen-du-prix-des-medicaments-brevetes\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/innovativemedicines.ca\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Newsroom\",\"item\":\"https:\/\/innovativemedicines.ca\/fr\/newsroom\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Blog\",\"item\":\"https:\/\/innovativemedicines.ca\/fr\/?page_id=9368\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"M\u00e9dicaments novateurs Canada r\u00e9agit \u00e0 la publication des Lignes directrices d\u00e9finitives du Conseil d\u2019examen du prix des m\u00e9dicaments brevet\u00e9s\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/innovativemedicines.ca\/fr\/#website\",\"url\":\"https:\/\/innovativemedicines.ca\/fr\/\",\"name\":\"Innovative Medicines Canada\",\"description\":\"Transforming Canadians\u2019 lives\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/innovativemedicines.ca\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/innovativemedicines.ca\/fr\/#\/schema\/person\/9c9782d644563c5e4084ca674198eaa9\",\"name\":\"Alex Chambers\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/innovativemedicines.ca\/fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/707b7d6d5da779f6d39dbb3b246eab77?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/707b7d6d5da779f6d39dbb3b246eab77?s=96&d=mm&r=g\",\"caption\":\"Alex Chambers\"},\"url\":\"https:\/\/innovativemedicines.ca\/fr\/blog\/author\/alexandrachambers\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"M\u00e9dicaments novateurs Canada r\u00e9agit \u00e0 la publication des Lignes directrices d\u00e9finitives du Conseil d\u2019examen du prix des m\u00e9dicaments brevet\u00e9s - Innovative Medicines Canada","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/innovativemedicines.ca\/fr\/actualites\/blogues\/medicaments-novateurs-canada-reagit-a-la-publication-des-lignes-directrices-definitives-du-conseil-dexamen-du-prix-des-medicaments-brevetes\/","og_locale":"fr_FR","og_type":"article","og_title":"M\u00e9dicaments novateurs Canada r\u00e9agit \u00e0 la publication des Lignes directrices d\u00e9finitives du Conseil d\u2019examen du prix des m\u00e9dicaments brevet\u00e9s - Innovative Medicines Canada","og_description":"D\u00c9CLARATION Ottawa, le 23 octobre 2020\u00a0\u2013 M\u00e9dicaments novateurs Canada (MNC) a fait la d\u00e9claration suivante en r\u00e9action \u00e0 la publication […]","og_url":"https:\/\/innovativemedicines.ca\/fr\/actualites\/blogues\/medicaments-novateurs-canada-reagit-a-la-publication-des-lignes-directrices-definitives-du-conseil-dexamen-du-prix-des-medicaments-brevetes\/","og_site_name":"Innovative Medicines Canada","article_published_time":"2020-10-23T21:41:23+00:00","og_image":[{"width":1920,"height":1281,"url":"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2022\/06\/terms-conditions-hero.jpg","type":"image\/jpeg"}],"author":"Alex Chambers","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Alex Chambers","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/blogues\/medicaments-novateurs-canada-reagit-a-la-publication-des-lignes-directrices-definitives-du-conseil-dexamen-du-prix-des-medicaments-brevetes\/","url":"https:\/\/innovativemedicines.ca\/fr\/actualites\/blogues\/medicaments-novateurs-canada-reagit-a-la-publication-des-lignes-directrices-definitives-du-conseil-dexamen-du-prix-des-medicaments-brevetes\/","name":"M\u00e9dicaments novateurs Canada r\u00e9agit \u00e0 la publication des Lignes directrices d\u00e9finitives du Conseil d\u2019examen du prix des m\u00e9dicaments brevet\u00e9s - Innovative Medicines Canada","isPartOf":{"@id":"https:\/\/innovativemedicines.ca\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/blogues\/medicaments-novateurs-canada-reagit-a-la-publication-des-lignes-directrices-definitives-du-conseil-dexamen-du-prix-des-medicaments-brevetes\/#primaryimage"},"image":{"@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/blogues\/medicaments-novateurs-canada-reagit-a-la-publication-des-lignes-directrices-definitives-du-conseil-dexamen-du-prix-des-medicaments-brevetes\/#primaryimage"},"thumbnailUrl":"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2022\/06\/terms-conditions-hero.jpg","datePublished":"2020-10-23T21:41:23+00:00","author":{"@id":"https:\/\/innovativemedicines.ca\/fr\/#\/schema\/person\/9c9782d644563c5e4084ca674198eaa9"},"breadcrumb":{"@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/blogues\/medicaments-novateurs-canada-reagit-a-la-publication-des-lignes-directrices-definitives-du-conseil-dexamen-du-prix-des-medicaments-brevetes\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/innovativemedicines.ca\/fr\/actualites\/blogues\/medicaments-novateurs-canada-reagit-a-la-publication-des-lignes-directrices-definitives-du-conseil-dexamen-du-prix-des-medicaments-brevetes\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/blogues\/medicaments-novateurs-canada-reagit-a-la-publication-des-lignes-directrices-definitives-du-conseil-dexamen-du-prix-des-medicaments-brevetes\/#primaryimage","url":"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2022\/06\/terms-conditions-hero.jpg","contentUrl":"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2022\/06\/terms-conditions-hero.jpg","width":1920,"height":1281},{"@type":"BreadcrumbList","@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/blogues\/medicaments-novateurs-canada-reagit-a-la-publication-des-lignes-directrices-definitives-du-conseil-dexamen-du-prix-des-medicaments-brevetes\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/innovativemedicines.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Newsroom","item":"https:\/\/innovativemedicines.ca\/fr\/newsroom\/"},{"@type":"ListItem","position":3,"name":"Blog","item":"https:\/\/innovativemedicines.ca\/fr\/?page_id=9368"},{"@type":"ListItem","position":4,"name":"M\u00e9dicaments novateurs Canada r\u00e9agit \u00e0 la publication des Lignes directrices d\u00e9finitives du Conseil d\u2019examen du prix des m\u00e9dicaments brevet\u00e9s"}]},{"@type":"WebSite","@id":"https:\/\/innovativemedicines.ca\/fr\/#website","url":"https:\/\/innovativemedicines.ca\/fr\/","name":"Innovative Medicines Canada","description":"Transforming Canadians\u2019 lives","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/innovativemedicines.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/innovativemedicines.ca\/fr\/#\/schema\/person\/9c9782d644563c5e4084ca674198eaa9","name":"Alex Chambers","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/innovativemedicines.ca\/fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/707b7d6d5da779f6d39dbb3b246eab77?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/707b7d6d5da779f6d39dbb3b246eab77?s=96&d=mm&r=g","caption":"Alex Chambers"},"url":"https:\/\/innovativemedicines.ca\/fr\/blog\/author\/alexandrachambers\/"}]}},"_links":{"self":[{"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/posts\/9254","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/comments?post=9254"}],"version-history":[{"count":0,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/posts\/9254\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/media\/13659"}],"wp:attachment":[{"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/media?parent=9254"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/categories?post=9254"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/tags?post=9254"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/topic?post=9254"},{"taxonomy":"team-member-id","embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/team-member-id?post=9254"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}